Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 15 May 2007
Vol. 2007, Issue 386, p. tw168
[DOI: 10.1126/stke.3862007tw168]


Wnt Signaling beta-catenin Activates ERK: Two Pathways for the Price of One

John F. Foley

Science’s STKE, AAAS, Washington, DC 20005, USA

Wnt/beta-catenin signaling is important for developmental processes, but this pathway is also associated with the development of certain cancers. Loss-of-function mutations in proteins involved in the negative regulation of Wnt/beta-catenin signaling, such as Axin, result in the accumulation of beta-catenin in the nucleus. This leads to the increased expression of beta-catenin-responsive genes and to cellular proliferation. Dysregulation of the extracellular signal-regulated kinase (ERK) pathway, such as in the case of cells with mutations in ras, also leads to cancers. To investigate a possible link between these two pathways in carcinogenesis, Jeon et al. established an L929 fibroblast cell line in which production of Axin was inducible by the addition of doxycycline (L929-Axin). Western blot analysis revealed that the increased abundance of Axin in L929-Axin cells inhibited the accumulation of beta-catenin, as expected, but also inhibited the phosphorylation of components of the ERK pathway, including Raf-1, MEK (mitogen-activated or extracellular signal-regulated protein kinase kinase), and ERK. L929-Axin cells showed a smaller proliferative response to epidermal growth factor (EGF) than did control cells, as measured by phosphorylation of Raf-1, MEK, and ERK. Flow-cytometry studies revealed that Axin also inhibited EGF-stimulated progression from the G1 to the S phase of the cell cycle. Negative regulation by Axin of the ERK pathway did not occur in cells containing a nondegradable mutant form of beta-catenin. Ras, a small guanosine triphosphatase that responds to growth factor signals and activates the ERK pathway, was less abundant in L929-Axin cells than in control cells. This reduction in Ras (which was mediated by lysosomal degradation) did not occur in cells containing nondegradable beta-catenin. These data suggest that beta-catenin signaling can also activate the ERK signaling pathway, thereby enhancing the likelihood of carcinogenesis.

S. H. Jeon, J.-Y. Yoon, Y.-N. Park, W.-J. Jeong, S. Kim, E.-H. Jho, Y.-J. Surh, K.-Y. Choi, Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin. J. Biol. Chem. 282, 14482-14492 (2007). [Abstract] [Full Text]

Citation: J. F. Foley, beta-catenin Activates ERK: Two Pathways for the Price of One. Sci. STKE 2007, tw168 (2007).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882